Patent · US Active

1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

US10316027B2 · kind B2 · utility

0Cited by

6References

3Claims

0Family size

Assignee

IMPACT THERAPEUTICS, INC. · CN

Inventors

Sui Xiong Cai · San Diego, US
Ye Tian · Bloomington, US
Haijun Dong · Shanghai, CN
Qingbing Xu · 安丰镇, CN
Lizhen Wu · 安丰镇, CN
Lijun Liu · 安丰镇, CN
Yangzhen Jiang · 安丰镇, CN
Qingli Bao · 安丰镇, CN
Guoxiang Wang · 安丰镇, CN
Feng Yin · 安丰镇, CN
Chengyun Gu · 安丰镇, CN
Xiuhua Hu · 安丰镇, CN
Xiaozhu WANG · 安丰镇, CN
Sishun Kang · 安丰镇, CN
Shengzhi Chen · 安丰镇, CN

Key dates

Filing date	Mar 26, 2018
Grant date	Jun 11, 2019
Priority date	—
Expiry date	Mar 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.